-
2024-515118-42-00
11
2024-09-10
Colorectal cancer
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2024-515788-73-00
4
2024-07-30
MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCER AND
A HIGH IM
-
2023-505298-34-00
4
2024-07-18
Patients with dMMR/MSI (non-colorectal/non-endometrial) locally advanc
-
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
-
2023-509761-21-00
5
2024-07-08
Metastatic colorectal cancer
-
2022-500013-32-01
5
2024-07-05
Adrenocortical carcinoma
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
-
2023-505214-23-00
5
2024-06-07
colon carcinoma
-
2023-505436-35-00
5
2024-06-03
Untreated FLIPI 2-5 Follicular Lymphoma
-
2023-504151-27-00
5
2024-05-09
Psychosis associated with Alzheimer’s Disease
-
2024-516456-17-00
5
2024-05-07
patients admitted for an obstructive colon cancer
-
2024-513371-41-00
4
2024-04-25
Severe uveitis of Behçet’s disease
-
2023-504044-34-00
4
2024-04-17
Untreated Chronic Lymphocytic Leukemia
-
2022-501554-11-00
4
2024-03-21
Patients with previously untreated Richter’s syndrome (RS), defined as
-
2022-501408-81-01
4
2024-03-04
Covid-19
-
2024-514101-65-00
4
2023-12-21
Multiple Myeloma
-
2023-506102-39-00
4
2023-12-18
metastatic gastric cancer
-
2024-512999-35-00
4
2023-06-23
Patients with HER 2 negative locally advanced, recurrent or metastatic
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2024-511896-13-00
11
2022-12-09
EA-COPD (with mechanical ventilation, invasive or non-invasive, or hig
-
2024-511899-32-00
10
2022-08-31
Dermatomyositis; Baricitinib in patients with relapsing or naïve derma
-
2022-503068-34-00
4
2022-04-06
Metastatic Gastrointestinal Stromal Tumor